Systematic tissue collection during clinical breast biopsy is feasible, safe and enables high-content translational analyses

Abstract Systematic collection of fresh tissues for research at the time of diagnostic image-guided breast biopsy has the potential to fuel a wide variety of innovative studies. Here we report the initial experience, including safety, feasibility, and laboratory proof-of-principle, with the collecti...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Siang-Boon Koh, Brian N. Dontchos, Veerle Bossuyt, Christine Edmonds, Simona Cristea, Nsan Melkonjan, Lindsey Mortensen, Annie Ma, Kassidy Beyerlin, Elyssa Denault, Elizabeth Niehoff, Taghreed Hirz, David B. Sykes, Franziska Michor, Michelle Specht, Constance Lehman, Leif W. Ellisen, Laura M. Spring
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Acceso en línea:https://doaj.org/article/bb4e9fd066134280a9174b2fe59dc262
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:bb4e9fd066134280a9174b2fe59dc262
record_format dspace
spelling oai:doaj.org-article:bb4e9fd066134280a9174b2fe59dc2622021-12-02T18:14:07ZSystematic tissue collection during clinical breast biopsy is feasible, safe and enables high-content translational analyses10.1038/s41698-021-00224-w2397-768Xhttps://doaj.org/article/bb4e9fd066134280a9174b2fe59dc2622021-09-01T00:00:00Zhttps://doi.org/10.1038/s41698-021-00224-whttps://doaj.org/toc/2397-768XAbstract Systematic collection of fresh tissues for research at the time of diagnostic image-guided breast biopsy has the potential to fuel a wide variety of innovative studies. Here we report the initial experience, including safety, feasibility, and laboratory proof-of-principle, with the collection and analysis of research specimens obtained via breast core needle biopsy immediately following routine clinical biopsy at a single institution over a 14-month period. Patients underwent one or two additional core biopsies following collection of all necessary clinical specimens. In total, 395 patients were approached and 270 consented to the research study, yielding a 68.4% consent rate. Among consenting patients, 238 lesions were biopsied for research, resulting in 446 research specimens collected. No immediate complications were observed. Representative research core specimens showed high diagnostic concordance with clinical core biopsies. Flow cytometry demonstrated consistent recovery of hundreds to thousands of viable cells per research core. Among a group of HER2 + tumor research specimens, HER2 assessment by flow cytometry correlated highly with immunohistochemistry (IHC) staining, and in addition revealed extensive inter- and intra-tumoral variation in HER2 levels of potential clinical relevance. Suitability for single-cell transcriptomic analysis was demonstrated for a triple-negative tumor core biopsy, revealing substantial cellular diversity in the tumor immune microenvironment, including a prognostically relevant T cell subpopulation. Thus, collection of fresh tissues for research purposes at the time of diagnostic breast biopsy is safe, feasible and efficient, and may provide a high-yield mechanism to generate a rich tissue repository for a wide variety of cross-disciplinary research.Siang-Boon KohBrian N. DontchosVeerle BossuytChristine EdmondsSimona CristeaNsan MelkonjanLindsey MortensenAnnie MaKassidy BeyerlinElyssa DenaultElizabeth NiehoffTaghreed HirzDavid B. SykesFranziska MichorMichelle SpechtConstance LehmanLeif W. EllisenLaura M. SpringNature PortfolioarticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENnpj Precision Oncology, Vol 5, Iss 1, Pp 1-7 (2021)
institution DOAJ
collection DOAJ
language EN
topic Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Siang-Boon Koh
Brian N. Dontchos
Veerle Bossuyt
Christine Edmonds
Simona Cristea
Nsan Melkonjan
Lindsey Mortensen
Annie Ma
Kassidy Beyerlin
Elyssa Denault
Elizabeth Niehoff
Taghreed Hirz
David B. Sykes
Franziska Michor
Michelle Specht
Constance Lehman
Leif W. Ellisen
Laura M. Spring
Systematic tissue collection during clinical breast biopsy is feasible, safe and enables high-content translational analyses
description Abstract Systematic collection of fresh tissues for research at the time of diagnostic image-guided breast biopsy has the potential to fuel a wide variety of innovative studies. Here we report the initial experience, including safety, feasibility, and laboratory proof-of-principle, with the collection and analysis of research specimens obtained via breast core needle biopsy immediately following routine clinical biopsy at a single institution over a 14-month period. Patients underwent one or two additional core biopsies following collection of all necessary clinical specimens. In total, 395 patients were approached and 270 consented to the research study, yielding a 68.4% consent rate. Among consenting patients, 238 lesions were biopsied for research, resulting in 446 research specimens collected. No immediate complications were observed. Representative research core specimens showed high diagnostic concordance with clinical core biopsies. Flow cytometry demonstrated consistent recovery of hundreds to thousands of viable cells per research core. Among a group of HER2 + tumor research specimens, HER2 assessment by flow cytometry correlated highly with immunohistochemistry (IHC) staining, and in addition revealed extensive inter- and intra-tumoral variation in HER2 levels of potential clinical relevance. Suitability for single-cell transcriptomic analysis was demonstrated for a triple-negative tumor core biopsy, revealing substantial cellular diversity in the tumor immune microenvironment, including a prognostically relevant T cell subpopulation. Thus, collection of fresh tissues for research purposes at the time of diagnostic breast biopsy is safe, feasible and efficient, and may provide a high-yield mechanism to generate a rich tissue repository for a wide variety of cross-disciplinary research.
format article
author Siang-Boon Koh
Brian N. Dontchos
Veerle Bossuyt
Christine Edmonds
Simona Cristea
Nsan Melkonjan
Lindsey Mortensen
Annie Ma
Kassidy Beyerlin
Elyssa Denault
Elizabeth Niehoff
Taghreed Hirz
David B. Sykes
Franziska Michor
Michelle Specht
Constance Lehman
Leif W. Ellisen
Laura M. Spring
author_facet Siang-Boon Koh
Brian N. Dontchos
Veerle Bossuyt
Christine Edmonds
Simona Cristea
Nsan Melkonjan
Lindsey Mortensen
Annie Ma
Kassidy Beyerlin
Elyssa Denault
Elizabeth Niehoff
Taghreed Hirz
David B. Sykes
Franziska Michor
Michelle Specht
Constance Lehman
Leif W. Ellisen
Laura M. Spring
author_sort Siang-Boon Koh
title Systematic tissue collection during clinical breast biopsy is feasible, safe and enables high-content translational analyses
title_short Systematic tissue collection during clinical breast biopsy is feasible, safe and enables high-content translational analyses
title_full Systematic tissue collection during clinical breast biopsy is feasible, safe and enables high-content translational analyses
title_fullStr Systematic tissue collection during clinical breast biopsy is feasible, safe and enables high-content translational analyses
title_full_unstemmed Systematic tissue collection during clinical breast biopsy is feasible, safe and enables high-content translational analyses
title_sort systematic tissue collection during clinical breast biopsy is feasible, safe and enables high-content translational analyses
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/bb4e9fd066134280a9174b2fe59dc262
work_keys_str_mv AT siangboonkoh systematictissuecollectionduringclinicalbreastbiopsyisfeasiblesafeandenableshighcontenttranslationalanalyses
AT brianndontchos systematictissuecollectionduringclinicalbreastbiopsyisfeasiblesafeandenableshighcontenttranslationalanalyses
AT veerlebossuyt systematictissuecollectionduringclinicalbreastbiopsyisfeasiblesafeandenableshighcontenttranslationalanalyses
AT christineedmonds systematictissuecollectionduringclinicalbreastbiopsyisfeasiblesafeandenableshighcontenttranslationalanalyses
AT simonacristea systematictissuecollectionduringclinicalbreastbiopsyisfeasiblesafeandenableshighcontenttranslationalanalyses
AT nsanmelkonjan systematictissuecollectionduringclinicalbreastbiopsyisfeasiblesafeandenableshighcontenttranslationalanalyses
AT lindseymortensen systematictissuecollectionduringclinicalbreastbiopsyisfeasiblesafeandenableshighcontenttranslationalanalyses
AT anniema systematictissuecollectionduringclinicalbreastbiopsyisfeasiblesafeandenableshighcontenttranslationalanalyses
AT kassidybeyerlin systematictissuecollectionduringclinicalbreastbiopsyisfeasiblesafeandenableshighcontenttranslationalanalyses
AT elyssadenault systematictissuecollectionduringclinicalbreastbiopsyisfeasiblesafeandenableshighcontenttranslationalanalyses
AT elizabethniehoff systematictissuecollectionduringclinicalbreastbiopsyisfeasiblesafeandenableshighcontenttranslationalanalyses
AT taghreedhirz systematictissuecollectionduringclinicalbreastbiopsyisfeasiblesafeandenableshighcontenttranslationalanalyses
AT davidbsykes systematictissuecollectionduringclinicalbreastbiopsyisfeasiblesafeandenableshighcontenttranslationalanalyses
AT franziskamichor systematictissuecollectionduringclinicalbreastbiopsyisfeasiblesafeandenableshighcontenttranslationalanalyses
AT michellespecht systematictissuecollectionduringclinicalbreastbiopsyisfeasiblesafeandenableshighcontenttranslationalanalyses
AT constancelehman systematictissuecollectionduringclinicalbreastbiopsyisfeasiblesafeandenableshighcontenttranslationalanalyses
AT leifwellisen systematictissuecollectionduringclinicalbreastbiopsyisfeasiblesafeandenableshighcontenttranslationalanalyses
AT lauramspring systematictissuecollectionduringclinicalbreastbiopsyisfeasiblesafeandenableshighcontenttranslationalanalyses
_version_ 1718378474027089920